666 related articles for article (PubMed ID: 978105)
61. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
62. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. III. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone acetate (DMPA).
Aedo AR; Landgren BM; Diczfalusy E
Contraception; 1981 Aug; 24(2):117-35. PubMed ID: 6457729
[TBL] [Abstract][Full Text] [Related]
63. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
Kekkonen R; Croxatto HB; Lähteenmäki P; Salvatierra AM; Tuominen J
Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
[TBL] [Abstract][Full Text] [Related]
64. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
65. Intravaginal contraception with the synthetic progestin, R2010.
Toivonen J
Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
[TBL] [Abstract][Full Text] [Related]
66. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
67. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
68. Pharmacokinetic study of different doses of Depo Provera.
Fotherby K; Koetsawang S; Mathrubutham M
Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
[TBL] [Abstract][Full Text] [Related]
69. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
[TBL] [Abstract][Full Text] [Related]
70. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
71. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
Parkington HC; Lipton A
J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
[TBL] [Abstract][Full Text] [Related]
72. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
73. Plasma gonadotropins and prolactin in pseudopregnancy in the rat.
Bishop W; Orias R; Fawcett CP; Krulich L; McCann SM
Proc Soc Exp Biol Med; 1971 Sep; 137(4):1411-4. PubMed ID: 5138472
[TBL] [Abstract][Full Text] [Related]
74. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis.
Barbieri RL; Ryan KJ
Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496
[TBL] [Abstract][Full Text] [Related]
75. Plasma hormones and pituitary luteinizing hormone in the rat during the early stages of pregnancy and after post-coital treatment with tamoxifen (ICI 46,474).
Watson J; Anderson FB; Alam M; O'Grady JE; Heald PJ
J Endocrinol; 1975 Apr; 65(1):7-17. PubMed ID: 1141814
[TBL] [Abstract][Full Text] [Related]
76. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
Alvarez F; Brache V; Tejada AS; Faúndes A
Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
[TBL] [Abstract][Full Text] [Related]
77. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
78. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
79. Changes in concentration of serum LH and FSH associated with estrogen-advanced ovulation in 4-day cyclic rats.
Ying SY; Fang VS; Greep RO
Proc Soc Exp Biol Med; 1972 Mar; 139(3):738-40. PubMed ID: 5063368
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]